Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, Stephen L.; Bar-Or, Amit; Comi, Giancarlo; Giovannoni, Gavin; Hartung, Hans-Peter; Hemmer, Bernhard; Lublin, Fred; Montalban, Xavier; Rammohan, Kottil W.; Selmaj, Krzysztof; Traboulsee, Anthony; Wolinsky, Jerry S.; Arnold, Douglas L.; Klingelschmitt, Gaelle; Masterman, Donna; Fontoura, Paulo; Belachew, Shibeshih; Chin, Peter; Mairon, Nicole; Garren, Hideki; Kappos, Ludwig; Elovaara, Irina; for the OPERA I and OPERA II Clinical Investigators (2017)
Hauser, Stephen L.
Bar-Or, Amit
Comi, Giancarlo
Giovannoni, Gavin
Hartung, Hans-Peter
Hemmer, Bernhard
Lublin, Fred
Montalban, Xavier
Rammohan, Kottil W.
Selmaj, Krzysztof
Traboulsee, Anthony
Wolinsky, Jerry S.
Arnold, Douglas L.
Klingelschmitt, Gaelle
Masterman, Donna
Fontoura, Paulo
Belachew, Shibeshih
Chin, Peter
Mairon, Nicole
Garren, Hideki
Kappos, Ludwig
Elovaara, Irina
for the OPERA I and OPERA II Clinical Investigators
2017
New England Journal of Medicine 376 3
221-234
Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.